Pharmacologic Management of High-Risk Neuroblastoma in Children

Author： Ganeshan Veena R.   Schor Nina F.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.4, 2011-08, pp. : 245-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma

By Furman Wayne  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1660-1670

Springer Publishing Company

Access to resources Recommend Favorite

Influenza vaccination worth it among high-risk children

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Palivizumab for RSV prevention in high-risk children

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Palivizumab for RSV prevention in high-risk children

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

FACTORS ASSOCIATED WITH INDISCRIMINATE FRIENDLINESS IN HIGH‐RISK CHILDREN

By  

Infant Mental Health Journal, Vol. 36, Iss. 4, 2015-07 ,pp. : 427-445

John Wiley & Sons Inc

Access to resources Recommend Favorite